Analysts await Achaogen, Inc. (NASDAQ:AKAO) to report earnings on Mar, 15 for the fiscal quarter ending Dec 2015.

They expect $-0.59 EPS, down 54.24% or $0.32 from last year’s $-0.27 per share.

At the moment 6 analysts are watching Achaogen, Inc. (NASDAQ:AKAO), 1 rate it “Buy”, 4 “Outperform”, 1 “Underperform”, 0 “Sell”, while 0 “Hold”.

Looking forward, for the quarter ending Mar-16, 3 analysts have a mean sales target of 5.60 million. For the quarter ending Jun-16, 3 analysts have a mean sales target of 5.60 million whilst for the year ending Dec-16, 6 analysts have a mean target of 21.89 million.

In terms of earnings per share, 3 analysts have a -0.57 EPS mean target for the quarter ending Mar-16, for the quarter ending Jun-16, 3 analysts have a -0.57 EPS mean target and for the quarter ending Jun-16 there are 6 estimates of -2.42 EPS.

Total shares held by institutions as of the most recent company filings are 15,175,089 with a reported 703,100 bought and 289,496 sold. These holdings make up 91.66% of the company’s outstanding shares.

The stock decreased 2.13% or $0.08 during the last trading session, hitting $4.27. Achaogen, Inc. (NASDAQ:AKAO) has fallen 62.76% over the past 6 months and is downtrending.